Zenith Alpha™ Abdominal Endovascular Graft

NCT03061825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-01-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Conditions

  • Abdominal Aortic
  • Aorto-iliac Aneurysm

Interventions

DEVICE

Zenith Alpha™ Abdominal Endovascular Graft

Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Principal Investigators

  • Thomas Forbes, MD · Toronto General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2021-01-06
Completion
2021-01-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03061825 on ClinicalTrials.gov